SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-23-015556
Filing Date
2023-11-27
Accepted
2023-11-27 08:45:23
Documents
8
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 j11152306k.htm 6-K 35063
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 250419
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 152240
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 53668
5 EXHIBIT 10.4 ex10_4.htm EX-10.4 255255
6 EXHIBIT 10.5 ex10_5.htm EX-10.5 154335
7 EXHIBIT 10.6 ex10_6.htm EX-10.6 52759
8 EXHIBIT 99.1 ex99_1.htm EX-99.1 23518
  Complete submission text file 0001214659-23-015556.txt   978379
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 231437409
SIC: 2834 Pharmaceutical Preparations